We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Introducing a New Tabletop System for Image Capture of Labeled Biomolecules

By LabMedica International staff writers
Posted on 07 May 2012
While designed with chemiluminescent Western blotting in mind, an innovative new image analysis instrument is able to handle a wide variety of stained media including fluorescent proteins, DNA gel stains, and white light imaging of colorimetric stains and markers.

The GE Healthcare (Chalfont St. More...
Giles, United Kingdom) ImageQuant LAS 500 was designed for fast and easy imaging of chemiluminescent Western blots. In addition, the system is fully equipped for Deep Purple Total Protein Stain, UV fluorescent DNA gels stained with SYBR Green or ethidium bromide, and Coomassie Blue or silver stained gels.

The system boasts optimized F/1.4 (30 mm) optics and a sensitive 8.3 megapixel closed circuit camera specifically for chemiluminescense. The fixed focus lens cools to -25 °C in less than five minutes, enabling rapid image capture. Combined with binning and advanced read-out technology this significantly reduces noise levels and improves both the sensitivity and linearity of the system so that protein in quantities as low as five picograms may be reliably quantitated.

The ImageQuant LAS 500 features an intelligent autoexposure system. There is no need to focus, adjust, or calibrate the instrument. The user simply selects the imaging method, and the system takes care of the rest.

All tasks on the ImageQuant LAS 500 are controlled via an integrated touchscreen including the automatic overlay function, which allows users to compare chemiluminescent samples to colored molecular weight markers and estimate the detected proteins’ size and orientation on the membrane. The ImageQuant LAS 500 instrument saves valuable space on the lab bench by being about the same size as a typical laptop computer (30 x 28 cm). The fully integrated system does not require a dedicated PC: using the intuitive analysis software; images can either be stored or transferred via a network connection to other devices.

Related Links:

GE Healthcare




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Electrolyte Analyzer
BKE-B
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers identified 157 metabolites linked to BBB damage, including 25 that appeared in at least two independent studies (Image Credit: Adobe Stock)

Blood Metabolite Patterns May Enable Early Detection of Blood-Brain Barrier Injury

Early injury to the blood-brain barrier (BBB) can precede many neurological disorders but remains difficult to detect noninvasively. Laboratory markers that identify barrier dysfunction before symptoms... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

Lung cancer remains the leading cause of cancer death in the United States, yet only about 18% of people eligible for screening undergo low-dose computed tomography, the current guideline-recommended method.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.